These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 17371435)
1. Molecular markers of circulating melanoma cells. Medic S; Pearce RL; Heenan PJ; Ziman M Pigment Cell Res; 2007 Apr; 20(2):80-91. PubMed ID: 17371435 [TBL] [Abstract][Full Text] [Related]
2. Multimarker quantitative real-time PCR detection of circulating melanoma cells in peripheral blood: relation to disease stage in melanoma patients. Koyanagi K; Kuo C; Nakagawa T; Mori T; Ueno H; Lorico AR; Wang HJ; Hseuh E; O'Day SJ; Hoon DS Clin Chem; 2005 Jun; 51(6):981-8. PubMed ID: 15817820 [TBL] [Abstract][Full Text] [Related]
3. Molecular test for the detection of tumor cells in blood and sentinel nodes of melanoma patients. Van der Velde-Zimmermann D; Roijers JF; Bouwens-Rombouts A; De Weger RA; De Graaf PW; Tilanus MG; Van den Tweel JG Am J Pathol; 1996 Sep; 149(3):759-64. PubMed ID: 8780380 [TBL] [Abstract][Full Text] [Related]
4. Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay. Hoon DS; Wang Y; Dale PS; Conrad AJ; Schmid P; Garrison D; Kuo C; Foshag LJ; Nizze AJ; Morton DL J Clin Oncol; 1995 Aug; 13(8):2109-16. PubMed ID: 7636555 [TBL] [Abstract][Full Text] [Related]
5. The clinical utility of multimarker RT-PCR in the detection of occult metastasis in patients with melanoma. Taback B; Morton DL; O'Day SJ; Nguyen DH; Nakayama T; Hoon DS Recent Results Cancer Res; 2001; 158():78-92. PubMed ID: 11092035 [TBL] [Abstract][Full Text] [Related]
6. Molecular detection of circulating tumor cells is an independent prognostic factor in patients with high-risk cutaneous melanoma. Mocellin S; Del Fiore P; Guarnieri L; Scalerta R; Foletto M; Chiarion V; Pilati P; Nitti D; Lise M; Rossi CR Int J Cancer; 2004 Sep; 111(5):741-5. PubMed ID: 15252844 [TBL] [Abstract][Full Text] [Related]
7. Liquid biopsy utility for the surveillance of cutaneous malignant melanoma patients. Huang SK; Hoon DS Mol Oncol; 2016 Mar; 10(3):450-63. PubMed ID: 26778792 [TBL] [Abstract][Full Text] [Related]
8. Tumor cell and circulating markers in melanoma: diagnosis, prognosis, and management. Kounalakis N; Goydos JS Curr Oncol Rep; 2005 Sep; 7(5):377-82. PubMed ID: 16091200 [TBL] [Abstract][Full Text] [Related]
9. Genetic factors in metastatic progression of cutaneous melanoma: the future role of circulating melanoma cells in prognosis and management. Ireland A; Millward M; Pearce R; Lee M; Ziman M Clin Exp Metastasis; 2011 Apr; 28(4):327-36. PubMed ID: 21311956 [TBL] [Abstract][Full Text] [Related]
10. Multimarker real-time reverse transcription-PCR for quantitative detection of melanoma-associated antigens: a novel possible staging method. Arenberger P; Arenbergerova M; Gkalpakiotis S; Lippert J; Stribrna J; Kremen J J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):56-64. PubMed ID: 18181974 [TBL] [Abstract][Full Text] [Related]